OTC · Basic Materials · Chemicals - Specialty
Novozymes A/S
NVZMY
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. CEO Ester Baiget · Market cap $32.9B.
$70.51
+1.00 · +1.44%
52w hi $75.2752w lo $49.90
40
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
1
0 buys · 1 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
No filings yet
No Form 4 filings on record. As the backfill progresses this will populate.
Section 02
Recent STOCK Act disclosures
1 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Jul 08 | Josh Gottheimer | House · NJ | Sell | $1,001 - $15,000 | $8K | 37 d | 40 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug